| Autor: |
Takagi M; Regenerative Medicine Research & Business Development Department, Shiseido Co., Ltd., Yokohama, Japan. Electronic address: masaya.takagi@shiseido.com., Kinoshita-Ise M; Department of Dermatology, Kyorin University Faculty of Medicine, Tokyo, Japan., Fukuyama M; Department of Dermatology, Kyorin University Faculty of Medicine, Tokyo, Japan., Aoki S; Regenerative Medicine Research & Business Development Department, Shiseido Co., Ltd., Yokohama, Japan., Nishikawa S; Regenerative Medicine Research & Business Development Department, Shiseido Co., Ltd., Yokohama, Japan., Miyoshi M; Regenerative Medicine Research & Business Development Department, Shiseido Co., Ltd., Yokohama, Japan., Sugimoto T; Regenerative Medicine Research & Business Development Department, Shiseido Co., Ltd., Yokohama, Japan., Yamazaki M; Regenerative Medicine Research & Business Development Department, Shiseido Co., Ltd., Yokohama, Japan., Ogo M; Regenerative Medicine Research & Business Development Department, Shiseido Co., Ltd., Yokohama, Japan., Ohyama M; Department of Dermatology, Kyorin University Faculty of Medicine, Tokyo, Japan. Electronic address: manabuohy@ks.kyorin-u.ac.jp. |
| Abstrakt: |
Competing Interests: Conflict of Interest The Department of Dermatology, Kyorin University Faculty of Medicine (Chair: M. Ohyama) receives a research grant related to this study from Shiseido Co., Ltd. M. Ohyama receives lecture fee from Shiseido Co., Ltd., and a research grant directly related to this study from Shiseido Co., Ltd., and that does not directory related with the submitted work from Advantest Corp. MT, SA, SN, MM, TS, MY, and M. Ogo are employees of Shiseido Co., Ltd. |
Full Text from ScienceDirect